Vulnerability in Oracle Java SE and GraalVM Products
CVE-2025-53066

7.5HIGH

Key Information:

Vendor

Oracle
Status
Oracle Java Se
Oracle Graalvm For Jdk
Oracle Graalvm Enterprise Edition
Vendor
CVE Published:
21 October 2025

What is CVE-2025-53066?

A vulnerability exists in Oracle Java SE and GraalVM products that allows unauthenticated attackers with network access to exploit weaknesses in the JAXP component. This can lead to unauthorized access to sensitive data or potentially grant complete access to all data managed by these platforms. The issue can be exploited through APIs that serve data, affecting Java deployments that rely on sandboxed environments. It is crucial for users of affected versions to apply the necessary updates to mitigate the risks associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Oracle GraalVM Enterprise Edition 21.3.15

Oracle GraalVM for JDK 17.0.16

Oracle GraalVM for JDK 21.0.8

References

https://www.oracle.com/security-alerts/cpuoct2025.html
vendor-advisory

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.